|Denaro||0,00 x 0|
|Lettera||0,00 x 0|
|Min-Max giorno||73,21 - 73,25|
|Intervallo di 52 settimane||73,21 - 73,25|
|Beta (5 anni mensile)||0,48|
|Rapporto PE (ttm)||17,49|
|Prossima data utili||27 lug 2021|
|Rendimento e dividendo (forward)||N/D (N/D)|
|Data ex dividendo||N/D|
|Stima target 1A||N/D|
Clayton-based managed health care giant Centene Corp. reported a lower-than-expected profit in the fourth quarter due to higher testing and treatment costs associated with COVID-19 pandemic, sending its shares down about 2% in pre-market on Tuesday.
Centene, a diversified multi-national healthcare enterprise, said it will acquire Magellan Health for $95 per share in cash for a total enterprise value of $2.2 billion as the Fortune 500 company is looking to scale its mental health services at a time when Americans struggle with mental health issues associated with the COVID-19 pandemic.